181 related articles for article (PubMed ID: 26827962)
1. Vitamin D Signaling Modulators in Cancer Therapy.
Luo W; Johnson CS; Trump DL
Vitam Horm; 2016; 100():433-72. PubMed ID: 26827962
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
[TBL] [Abstract][Full Text] [Related]
3. 1α,25-dihydroxyvitamin D3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization.
Woeckel VJ; Bruedigam C; Koedam M; Chiba H; van der Eerden BC; van Leeuwen JP
Gene; 2013 Jan; 512(2):438-43. PubMed ID: 22967709
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.
Roberts JM; Martin RS; Piyarathna DB; MacKrell JG; Rocha GV; Dodge JA; Coarfa C; Krishnan V; Rowley DR; Weigel NL
Oncotarget; 2017 Jul; 8(27):44447-44464. PubMed ID: 28591703
[TBL] [Abstract][Full Text] [Related]
5. Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells.
Richard CL; Farach-Carson MC; Rohe B; Nemere I; Meckling KA
Exp Cell Res; 2010 Mar; 316(5):695-703. PubMed ID: 20036234
[TBL] [Abstract][Full Text] [Related]
6. The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
Kim JS; Roberts JM; Bingman WE; Shao L; Wang J; Ittmann MM; Weigel NL
Endocrinology; 2014 Sep; 155(9):3262-73. PubMed ID: 24926821
[TBL] [Abstract][Full Text] [Related]
7. VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells.
Solomon JD; Heitzer MD; Liu TT; Beumer JH; Parise RA; Normolle DP; Leach DA; Buchanan G; DeFranco DB
Mol Cancer Res; 2014 Aug; 12(8):1166-80. PubMed ID: 24825850
[TBL] [Abstract][Full Text] [Related]
8. Differential response of lung cancer cell lines to vitamin D derivatives depending on EGFR, KRAS, p53 mutation status and VDR polymorphism.
Maj E; Trynda J; Maj B; Gębura K; Bogunia-Kubik K; Chodyński M; Kutner A; Wietrzyk J
J Steroid Biochem Mol Biol; 2019 Oct; 193():105431. PubMed ID: 31326626
[TBL] [Abstract][Full Text] [Related]
9. The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages.
Matsunawa M; Amano Y; Endo K; Uno S; Sakaki T; Yamada S; Makishima M
Toxicol Sci; 2009 May; 109(1):50-8. PubMed ID: 19244278
[TBL] [Abstract][Full Text] [Related]
10. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D in thyroid tumorigenesis and development.
Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
[TBL] [Abstract][Full Text] [Related]
12. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
14. Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases.
Studzinski GP; McLane JA; Uskoković MR
Crit Rev Eukaryot Gene Expr; 1993; 3(4):279-312. PubMed ID: 8286848
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Analogs Regulate the Vitamin D System and Cell Viability in Ovarian Cancer Cells.
Piatek K; Kutner A; Cacsire Castillo-Tong D; Manhardt T; Kupper N; Nowak U; Chodyński M; Marcinkowska E; Kallay E; Schepelmann M
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008598
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor (VDR) regulation of voltage-gated chloride channels by ligands preferring a VDR-alternative pocket (VDR-AP).
Menegaz D; Mizwicki MT; Barrientos-Duran A; Chen N; Henry HL; Norman AW
Mol Endocrinol; 2011 Aug; 25(8):1289-300. PubMed ID: 21659475
[TBL] [Abstract][Full Text] [Related]
17. Snail-1 regulates VDR signaling and inhibits 1,25(OH)-D₃ action in osteosarcoma.
Yang H; Zhang Y; Zhou Z; Jiang X; Shen A
Eur J Pharmacol; 2011 Nov; 670(2-3):341-6. PubMed ID: 21963453
[TBL] [Abstract][Full Text] [Related]
18. RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression.
Quarni W; Lungchukiet P; Tse A; Wang P; Sun Y; Kasiappan R; Wu JY; Zhang X; Bai W
J Steroid Biochem Mol Biol; 2017 Oct; 173():157-167. PubMed ID: 28159673
[TBL] [Abstract][Full Text] [Related]
19. CYP24A1 as a potential target for cancer therapy.
Sakaki T; Yasuda K; Kittaka A; Yamamoto K; Chen TC
Anticancer Agents Med Chem; 2014 Jan; 14(1):97-108. PubMed ID: 23869781
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D
Bunch BL; Ma Y; Attwood K; Amable L; Luo W; Morrison C; Guru KA; Woloszynska-Read A; Hershberger PA; Trump DL; Johnson CS
Cancer Med; 2019 May; 8(5):2449-2461. PubMed ID: 30972950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
